(Q36770489)

16 August 2017

1 reference

title

Cell therapy for left ventricular remodeling (English)

1 reference

16 August 2017

Doris A Taylor

1

1 reference

PubMed ID

17386179

16 August 2017

Andrey G Zenovich

series ordinal

2

1 reference

16 August 2017

1 March 2007

1 reference

Current heart failure reports

16 August 2017

1 reference

16 August 2017

4

1 reference

16 August 2017

3-10

1 reference

16 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-007-0019-0

16 August 2017

0 references

cites work

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

1 reference

12 December 2020

Angiogenesis: where do we stand now?

1 reference

12 December 2020

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

1 reference

12 December 2020

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up

1 reference

12 December 2020

Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy

1 reference

12 December 2020

Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry

1 reference

12 December 2020

Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up.

1 reference

12 December 2020

Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation.

1 reference

12 December 2020

Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial

1 reference

12 December 2020

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

12 December 2020

Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial.

1 reference

12 December 2020

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

1 reference

12 December 2020

Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction

1 reference

12 December 2020

Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.

1 reference

12 December 2020

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

1 reference

12 December 2020

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Acute myocardial infarction and heart failure: role of apoptosis

1 reference

12 December 2020

Cardiac Magnetic Resonance Imaging for the Assessment of Myocardial Angiogenesis

1 reference

12 December 2020

Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy

1 reference

12 December 2020

Cardiac cell therapy--mixed results from mixed cells

1 reference

12 December 2020

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

1 reference

12 December 2020

New concepts in post-infarction ventricular remodeling

1 reference

12 December 2020

Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction

1 reference

12 December 2020

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

1 reference

12 December 2020

Are stem cells drugs? The regulation of stem cell research and development

1 reference

12 December 2020

Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty

1 reference

12 December 2020

Long-Term Trends in the Incidence of and Survival with Heart Failure

1 reference

12 December 2020

Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial

1 reference

12 December 2020

Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions

1 reference

12 December 2020

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial

1 reference

12 December 2020

Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC.

1 reference

12 December 2020

Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up

1 reference

12 December 2020

Aging, progenitor cell exhaustion, and atherosclerosis

1 reference

12 December 2020

10.1007/S11897-007-0019-0

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17386179